Research suggests that depression can increase the risk of sudden cardiac death and fatal coronary heart disease in women. Women with more severe depressive symptoms or those who reported taking antidepressants were at higher risk for these events.
Research found that relatively healthy women with severe depression are at increased risk of cardiac events, including SCD and fatal CHD. Antidepressant use was strongly associated with this risk, particularly Sudden Cardiac Death.
A study found that anger and hostility are associated with a higher risk of coronary heart disease (CHD) in healthy individuals and poorer outcomes in patients with existing CHD. Management of psychological stressors may be an important strategy for prevention and treatment.
A study published by the American College of Cardiology found that changes brought on by anger can predict future arrhythmias in patients with ICDs. Patients who experienced higher levels of anger-induced TWA were more likely to have arrhythmias requiring ICD termination.
Researchers found that one-year survival of elderly patients undergoing percutaneous coronary intervention was comparable to younger patients. Data suggest age alone should not prevent more aggressive care in these patients.
A new study published in JACC: Cardiovascular Interventions found significant improvement in migraines following catheter-based closure of patent foramen ovale. Patients with severe migraine, large PFO, and silent brain lesions showed greater numbers of patients who had cessation of migraine attacks and over 50% reduction in migraine a...
New research published in JACC found that patients have a better chance of survival when both their hospital and physician have a strong track record in treating heart attacks with angioplasty and stenting. High-volume hospitals and physicians performed significantly better, with lower risks of in-hospital death.
The number of female cardiologists has nearly doubled over the past decade, yet women still account for less than 20% of all cardiologists. Women face significant challenges, including work-life balance, radiation exposure concerns, and personal roadblocks to career advancement.
Research finds that depression and anxiety are associated with increased cardiovascular risk, particularly smoking and physical inactivity. A study of over 6,500 participants found that these factors alone accounted for nearly two-thirds of the risk of heart attack and other cardiovascular illnesses.
A growing body of evidence links low vitamin D levels to common CVD risk factors such as hypertension, obesity and diabetes. Researchers recommend screening and treating vitamin D deficiency in patients with risk factors for heart disease or diabetes.
The new clinical performance measures provide up-to-date tools for gauging how closely doctors are sticking to guideline recommendations. Key areas include statin prescription, PCI timeliness, referral to cardiac rehabilitation programs, and elimination of beta blocker treatment within 24 hours.
The document provides a comprehensive assessment of care by establishing new performance measures, including the importance of acute reperfusion therapy and the need for accountability in providing timely treatment. It also addresses concerns about exclusion criteria and the determination of when measurement stops.
The guidelines provide clinical features, diagnosis, and treatment information for a range of congenital heart defects. They also highlight key issues to look for during follow-up and make recommendations on genetic testing, pregnancy, contraception, and physical activity.
Research shows air pollution damages heart and blood vessels, leading to increased rates of hospitalization for cardiac illness and even death. Exposure to ultrafine pollutants triggers an inflammatory response that can cause arrhythmias and speed the progression of atherosclerosis.
Researchers found that a lifetime of eating tuna, sardines, salmon and other fish appears to protect Japanese men against clogged arteries despite other cardiovascular risk factors. Omega-3 fatty acids from fish were linked to low levels of atherosclerosis.
A recent study found that pregnancy increases a woman's risk of heart attack 3-4 fold. The study provides key recommendations for diagnosing and managing this condition in pregnant women, considering both maternal and fetal health.
Research suggests that high-flavanol cocoa can improve blood vessel function in people with type 2 diabetes, rivaling the benefits of exercise and common medications. Flavanols may help increase nitric oxide production, reducing artery stress and promoting cardiovascular health.
Two studies found that erectile dysfunction is a powerful early warning sign for serious heart disease, including heart attack and death in men with type 2 diabetes. Cholesterol-lowering medications and certain compounds like Viagra may reduce the risk of heart problems.
A recent study found that patients taking statins were 61% less likely to develop atrial fibrillation. The American College of Cardiology also releases new performance measures for monitoring AF care, which focus on stroke prevention through medication and regular monitoring.
New research published in the Journal of the American College of Cardiology reveals that longstanding anxiety markedly increases the risk of heart attack, even when other cardiovascular risk factors are taken into account. Anxiety is unique among psychological factors in predicting heart disease risk.
A new study found that a two-in-one test examining the nervous system and heart's electrical system can identify patients at highest risk of cardiac arrest or death after a heart attack. The REFINE study revealed that combining findings from one simple test makes it significantly more likely to identify high-risk patients.
Recent research suggests that decades of progress in reducing young adult coronary disease risk appears to be stalling. The worrisome plateau is likely caused by poor health habits such as smoking, lack of physical activity, and excessive weight gain.
Women who overcome breast cancer are at a higher risk of developing cardiovascular disease due to therapies that damage the heart and blood vessels. Exercise is crucial in maintaining heart health during treatment, and early evaluation of cardiovascular risk factors can help prevent complications.
A new study shows that a moderate bulge at the waist significantly increases the risk of unhealthy plaque build-up in the arteries. Researchers found that adding several inches to the waist measurement markedly increases the risk, even if body weight remains within a normal range.
The revised guidelines introduce changes to the initial diagnostic approach, recommending a non-invasive set of preliminary tests such as stress tests or echocardiograms. The new guidelines also emphasize the importance of more intense lipid and blood pressure control, as well as the use of anti-platelet therapy clopidogrel for at leas...
A new study published by the American College of Cardiology found an association between low cholesterol levels and increased cancer risk. The research suggests that patients with high doses of statins may be at a higher risk of developing certain types of cancer.
A new study found high levels of MPO to signal increased risk for heart disease nearly a decade before conventional risk factors set off alarms. Elevated MPO levels also indicate unstable plaque and may be used to detect vulnerable patients.
Research found that aerobic exercise, such as walking or bicycling, significantly improved ejection fraction and reduced heart size in patients with stable heart failure. In contrast, combining aerobic exercise with strength training showed no similar benefits.
Research shows that highly anxious patients with heart disease face nearly double the risk of heart attack or death compared to those with a more serene outlook on life. Patients who started out highly anxious but later found inner calm markedly reduced their risk.
Research shows that elderly patients (90+ years) who receive recommended treatments for acute coronary syndromes have better survival rates, but at a higher risk of bleeding complications. Guidelines must be balanced to balance survival benefits with increased bleeding risk.
A study assessed whether adding succinobucol, a novel agent with antioxidant and anti-inflammatory properties, to optimal medical therapy reduces coronary events and death. The trial achieved a 19% relative risk reduction in hard atherosclerotic clinical endpoints, including cardiovascular death, myocardial infarction, and stroke.
A randomized trial found that Crataegus Extract WS1442 safely prolongs the lives of congestive heart failure patients, reducing cardiac-related deaths by 20%. The study involved 2,681 patients and confirmed the safety of the compound, which is currently approved for use in some European countries.
A new implantable device has shown to effectively maintain heart function in transplant-listed patients, improving survival rates and quality of life. The study also explores the benefits of diuretic therapies in supporting left ventricular function, with promising results.
The MERLIN TIMI-36 study found that ranolazine reduced recurrent ischemia but not cardiovascular death or heart attack in patients with non-ST elevation acute coronary syndromes. The study provided new safety data on the drug's long-term use in high-risk patients.
Researchers found clevidipine to be more effective in controlling blood pressure compared to nitroglycerin and nicardipine. Measuring pro-B-type natriuretic peptide levels can help diagnose cardiac versus pulmonary dyspnea.
According to two studies, disease management programs designed with repetitive education and close monitoring can reduce hospital visits and increase heart failure patients' chances of long-term survival. The REMADHE study found that patients who received a nurse-based program spent an average of nine fewer days in the hospital.
Researchers have identified promising new drug combinations that can improve survival rates among patients with severe heart disease. Studies show that using imaging technologies like PET-guided therapy can also help doctors make more accurate decisions about therapies for these high-risk patients.
A new study found that CSL-111, a drug that mimics HDL, did not significantly reduce plaque in coronary arteries, but showed improvement in two indexes assessing blood vessel changes. The trial involved 183 patients with acute coronary syndromes and used intravenous ultrasound to assess coronary artery changes.
A study published in the New England Journal of Medicine found that pairing percutaneous coronary interventions (PCI) with optimal medical therapy (OMT) is no more effective than OMT alone in preventing heart attacks and other cardiac events. The study showed similar rates of death, heart attack, or stroke between patients who received...
Research on silent myocardial ischemia shows that anti-anginal therapy, combined with risk factor control, improves outcomes and preserves left ventricular function. Additionally, faster door-to-balloon time for STEMI patients leads to reduced healthcare costs, heart attack rates, and hospital stays.
Researchers found that combining torcetrapib with atorvastatin did not slow the progression of atherosclerosis, contrary to expectations. The study also noted significant increases in HDL-C and decreases in LDL-C levels.
A study by the American College of Cardiology found that torcetrapib increased good cholesterol levels but failed to slow plaque buildup in coronary arteries. The drug also raised blood pressure, leading researchers to question its efficacy as a treatment for cardiovascular disease.
Researchers present three studies highlighting advances in clinical cardiology, including a new drug-exercise combination that improves image quality and reduces side effects. The studies also explore the best medical and interventional treatment for patients with acute coronary syndromes.
A recent study found that combining a platelet inhibitor with an embolic protection device improves renal function in patients undergoing renal artery stenting. The use of abciximab reduced the occurrence of platelet-rich thrombi, while Angioguard alone was not associated with improved outcomes.
Researchers studied the effectiveness of estradiol and rapamycin-eluting stents in reducing in-stent restenosis. However, they found no significant difference between the two groups, indicating that adding estradiol to rapamycin-coated stents may not provide a measurable benefit.
The EXACT study found that community hospital physicians can provide exemplary outcomes for patients in need of carotid stenting with appropriate experience levels and device training. The use of embolic protection devices has been shown to reduce peri-procedural complications by 4.5% compared to the SECuRITY study.
Long-term safety of drug-eluting stents in off-label use shows low mortality rates, with cardiac mortality at 0.8%, but high risk of late stent thrombosis among non-responders to clopidogrel. The MATRIX Registry found that 34% of patients had diabetes and 33% a history of heart attack.
A randomized controlled trial found that peri-procedural hydration treatment with sodium bicarbonate and sodium chloride show similar rates of protection against contrast-induced nephropathy. The study evaluated 353 patients undergoing cardiac procedures and found no significant differences in kidney function between the two groups.
A combination of aliskiren and valsartan showed improved blood pressure control compared to individual treatments or placebo. The dual renin system blocking drug combo reduced systolic and diastolic blood pressure, achieving a goal blood pressure of 140/90 mmHg in 49.3% of patients.
A Phase 1 study evaluating a novel protein kinase C inhibitor, KAI-9803, suggests potential benefit in healing time and tissue function for heart attack patients. The trial showed improved tissue perfusion and reduced infarct size at lower dose levels.